Bregua Corporation: Funding, Team & Investors | Startup Intros

Loading organizations...

Bregua Corporation: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 20, 2024	Valora Therapeutics	$30.0M Seed	Avalon BioVentures, Bregua Corporation, Tiger Gene	—
Apr 1, 2024	Enlaza Therapeutics	$100.0M Series A	Stephen Squinto	.406 Ventures, Ascension Ventures, Atlas Venture, Avalon Ventures, Frazier Healthcare Partners, OrbiMed, Samsara BioCapital, Alexandria Venture Investments, Amgen Ventures, James Topper, Shelley Chu, Pappas Capital, Regeneron Ventures
Apr 1, 2021	Janux Therapeutics	$130.0M Series B	RA Capital Management	Avalon Ventures, Domain Associates, OrbiMed, Osage University Partners, Pivotal bioVenture Partners, RA Capital, RiverVest, Jonathan Root, Heather Preston, BVF Partners, EcoR1 Capital, Hartford HealthCare Endowment, Janus Henderson Investors, Logos Capital, Samsara BioCapital, Surveyor Capital
Mar 29, 2021	Fortis Therapeutics	$40.0M Series A	—	Avalon Ventures, Fulcrum 2020, Lilly Asia Ventures, Myeloma Investment Fund, Osage University Partners, Vivo Capital
Mar 1, 2021	Janux Therapeutics	$56.0M Series A	Avalon Ventures	Domain Associates, OrbiMed, Osage University Partners, Pivotal bioVenture Partners, RA Capital, RiverVest, Jonathan Root, Heather Preston, Correlation Ventures, Jake Simson
May 14, 2018	Acousia Therapeutics	$11.9M Series B	Harald Poth	Frank Kalkbrenner, KfW
Sep 27, 2016	Fortis Therapeutics	$18.0M Series A	Jay Lichter	Lilly Asia Ventures, Osage University Partners, Vivo Capital
Aug 1, 2016	Avelas Biosciences	$20.0M Series C	Andrei Petrov	Avalon Ventures, Alexandria Venture Investments, Ervington Investments, WuXi Healthcare Ventures